Efficacy of Neoadjuvant Single or Dual Anti-HER-2 Therapy Combined with Chemotherapy in Patients with HER-2-Positive Breast Cancer: A Single-Center Retrospective Study

Volume 22, Issue 5, May 2021, Pages 1467-1475

Qian He; Jia-Yi Li; Qing-Lan Ren

• View Article
• PDF 520.63 K

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer

Volume 22, Issue 5, May 2021, Pages 1607-1611

Qi Zhang; Jianwei Liang; Jianan Chen; Shiwen Mei; Zheng Wang

• View Article
• PDF 271.73 K

Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in Iranian Breast Cancer Patients

Volume 19, Issue 9, September 2018, Pages 2423-2427

Pegah Sasanpour; Saleh Sandoughdaran; Alireza Mosavi-Jarrahi; Mona Malekzadeh

• View Article
• PDF 260.15 K

The Neutrophil to Lymphocyte Ratio has a High Negative Predictive Value for Pathologic Complete Response in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Volume 15, Issue 18, December 2014, Pages 7737-7740

• View Article
• PDF 330.96 K